azilsartan and Breast-Neoplasms

azilsartan has been researched along with Breast-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for azilsartan and Breast-Neoplasms

Article	Year
Inhibition of NF-kB/IL-6/JAK2/STAT3 Pathway and Epithelial-Mesenchymal Transition in Breast Cancer Cells by Azilsartan. Molecules (Basel, Switzerland), 2022, Nov-13, Volume: 27, Issue:22 Topics: bcl-2-Associated X Protein; Breast Neoplasms; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Female; Humans; Interleukin-6; Janus Kinase 2; Matrix Metalloproteinase 9; NF-kappa B; RNA, Messenger; STAT3 Transcription Factor	2022

Article

Year

Inhibition of NF-kB/IL-6/JAK2/STAT3 Pathway and Epithelial-Mesenchymal Transition in Breast Cancer Cells by Azilsartan.

Molecules (Basel, Switzerland), 2022, Nov-13, Volume: 27, Issue:22

Topics: bcl-2-Associated X Protein; Breast Neoplasms; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Female; Humans; Interleukin-6; Janus Kinase 2; Matrix Metalloproteinase 9; NF-kappa B; RNA, Messenger; STAT3 Transcription Factor

2022